AccentedTouch

New research found out that by reducing the physical activity could weaken the glycemic control or the control of blood sugar levels and researchers suggests that inactivity could eventually increase the risk of developing type 2 diabetes.

The Centers of Disease Control Programs said that 79 million Americans have prediabetes and will probably develop diabetes later in life.

“We now have evidence that physical activity is an important part of the daily maintenance of glucose levels,” said John Thyfault an assistant professor in Missouri University’s departments of Nutrition and Exercise physiology and Internal Medicine. “Even in the short term, reducing daily activity and ceasing regular exercise causes acute changes in the body associated with diabetes that can occur before weight gain and the development of obesity.” http://www.medicaldaily.com/news/20110824/7057/type-ii-diabetes-type-2-diabetes-incerase-risk-of-diabetes-inactivity-reduced-activity-ppg.htm

Thyfault considered the relation linking low levels of physical activity and elevated levels of postproandial glucose (PPG) the quantity of a kind of sugar, called glucose, in the blood following a meal. PPG has been connected with greater than before risk for type 2 diabetes.

On the study, the researchers followed those levels of activity as well as the diet of health and moderately active young adults. The participants then reduced by half their physical activity for three days while progressing their practice diet behaviour when they were lively. Constant glucose monitors damaged by the participants demonstrated that during the time of inactivity there was a major increase level of PPG.

Thyfault added that it is suggested that people take about 10,000 steps each day because the recent proof shows that mainly Americans are only taking concerning half of that, or 5,000 steps a day. This constant inactivity leads to weakened glucose manage and increases the risk of developing diabetes.

According to the new research, it was found out that Mexican American faces an increase risk of developing type 2 diabetes compared to Anglo Americans and much more to those that are living in Mexico.

“The long-term San Antonio Heart Study, which monitored thousands of people over a 30-year period, showed that Anglo American diabeticshad twice the chance of non-diabetics of dying, while Mexican Americans faced three times the risk and people with diabetes living in Mexico City were four times more likely to die.” http://www.diabetes.co.uk/news/2011/Aug/mexican-americans-at-greater-diabetes-risk-than-anglos-99475136.html

Furthermore, risk of death is almost the same in spite of the race of an individual. But, research that was published in the Annals of Epidemiology was according to the data that was taken before the introduction of the new developments in the treatment of diabetes, also awareness of the effects.

Factors like poverty and social deprivation that were not into account that separates the health reasons from environmental ones is behind the findings.

Kelly Hunt, researcher, says that even though the occurence of diabetes is so much superior in Mexican Americans than in non-Hispanic whites, it wouldn’t be all that astonishing to him that if the strictness of the disease was in some way worse, but it’s hard to measure that.

Women who works at night shift for a long period of time appears to have an increased risk of having type 2 diabetes according to previous studies. According to working on the night shift stops the cardiac rhythm and is linked with obesity, metabolic syndrome and glucose dYsregulation. The study found out that even after adjusting for the BMI, the risk for type 2 diabetes remains higher.

“Researchers evaluated the association between night shift and diabetes within two large cohorts, the Nurses’ Health Study I and II. They followed more than 69,000 women aged 42 to 67 years from 1988 to 2008 in the Nurses’ Health Study I and more than 107,000 women aged 25 to 42 years from 1989 to 2007 in the Nurses’ Health Study II. Participants were questioned about how long they had worked rotating night shifts, which was defined as working at least three nights per month in addition to days and evenings in that month.” http://www.endocrinetoday.com/view.aspx?rid=85339

Researchers said, overall, 6,165 and 3,961 occurrence type 2 diabetes cases were recognized in the Nurses’ Health Study I and II, correspondingly. The period of shift work was linked with an augmented risk for type 2 diabetes in both cohorts, according to age-adjusted models (P<.001). This relationship was attenuated when the researchers controlled for other covariates, not including BMI. Additional alteration for BMI largely attenuated the relationship.

The researchers concluded that the results recommends that the women have increased risk in type 2 diabetes after extended period shift work, and the link appears to be mainly mediated through BMI.

“Using metformin as a way of treating type 2 diabetes has been shown to help reduce the risk of developing the condition, as well as lowering healthcare costs, according to a new study from the United States.” http://www.diabetes.co.uk/news/2011/Jun/metformin-helps-to-slow-diabetes-and-reduce-health-costs-94894214.html

National Institutes of Health scheme found out that by implementing an intensive intervention in lifestyle, it was better in reducing the risk of developing diabetes as compared with metformin, but it cost much more over a 10 year period.

On the study, they compared the use of diabetes drug metformin with a programme for a lifestyle intervention that aims to help people lose at least 7 percent of their body weight in a way of diet and taking more exercises together with behavioural counselling. People taking part in the research were overweight and experiencing a high levels of blood sugar, putting them at danger of developing type 2 diabetes.

Scientists measured the rate of the medical care equally in and outside the study, such as the cost of both metformin, which is typically accessible to patients just diagnosed with type 2 diabetes, and the lifestyle intervention. It was found that over the first three years, the lifestyle intervention abridged the risk of developing diabetes by 58 per cent, and that metformin reduced it by 31 per cent, compared to those patients who received no treatment at all.

For the full 10 years of the research, patients in the lifestyle intervention group experienced 31 per cent a lesser amount of danger of developing diabetes, while patients on metformin saw a decrease of 19 per cent compared to patients who received no treatment.

This week, the Bloomberg News report said that those who consume a cholesterol lowering drugs like Crestor in a high dose will most likely face a great risk on developing diabetes compared to those who take smaller dose. It came from hills of dosage that is related to the warning that involves Zocor which is also a cholesterol lowering drug.

According to the article, the research was based on the published work from last year that claims that those who take statins like the Crestor have high risk of developing diabetes compared to those who take placebo. The researchers assert that the diabetes risk is in proportion with the amount of the medicine that is taken, hence, the high dose of the medicine means high risk of developing the disease.

On the article, it is noted that the findings were based of on the five trials that was published in the Journal American Medical Association that have a 33,000 patients to study the effect of the dosage. The findings concluded that those who have intensive treatment were more likely to have the disease.

New York Times information claimed that doctors are now hesitant why the medication is connected to advanced levels of type 2 diabetes, but that they engage high blood sugar levels. The article declares that animal studies have recommended that the statins can augment battle to insulin, signalling higher levels of blood sugar.

Crestor is a statin drug which intends to decrease the quantity of cholesterol and other fatty substances in the blood. These inhibitors slow down the overall production of cholesterol in the body. Crestor is typically taken to assist reduce the option of getting heart disease, chest pain, stroke, and heart attacks. These statins are one of the highest selling drugs within the US, totalling near $15 billion for the year 2008.

“This is not the first time that Crestor has been related to some dangerous side effects. In the past, the drug has been related to side effects like tissue damage in the muscles, as well as kidney failure. In 2005, the FDA issued a warning update involving Crestor and other statins in which it named then as risks for muscle damage known as rhabdomyolysis, which is a possible side effect. This could deplete muscle strength and mass within the body, particularly in the heart tissue, bringing forth possible risk of heart conditions. As of now, every type of statin contains a warning relating to rhabdomyolysis and myopathy.” http://www.drugalert.org/news/2011/06/23/crestor-diabetes-risk-goes-high-dosage